11/7/26 Leveraging Natural History and RWE for Rare Approvals Previous The Plausible Mechanism Pathway: A New Evidence Playbook for Rare Disease Development Next Accelerated Pathways and Global Harmonization You Might Also Like Practical Application of Bayesian Networks in Rare Disease Trials Retention by Design - Keeping Families Engaged for Multi-Year Studies From Awareness to Activation - Converting Rare Patient Identification into Trial Enrollment Inside the FDA Mindset - Negotiating Endpoints and Surrogates Platform and Basket Trials in Rare Disease: What’s Working, What Isn’t, and What It Takes to Scale
11/7/26 Leveraging Natural History and RWE for Rare Approvals Previous The Plausible Mechanism Pathway: A New Evidence Playbook for Rare Disease Development Next Accelerated Pathways and Global Harmonization You Might Also Like Practical Application of Bayesian Networks in Rare Disease Trials Retention by Design - Keeping Families Engaged for Multi-Year Studies From Awareness to Activation - Converting Rare Patient Identification into Trial Enrollment Inside the FDA Mindset - Negotiating Endpoints and Surrogates Platform and Basket Trials in Rare Disease: What’s Working, What Isn’t, and What It Takes to Scale
